Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anitra Fielding
AstraZeneca Senior Research Physician
Study Director - Christian Rolfo
UZ Antwerpen
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Brno, Czechia
- Research Site
Bordeaux, France
- Research Site
Bordeaux, France
- Research Site
Dijon, France
- Research Site
Grenoble, France
- Research Site
Lyon, France
- Research Site
Paris, France
- Research Site
Amsterdam, Netherlands
- Research Site
Maastricht, Netherlands
- Research Site
Seoul, South Korea
- Research Site
London, United Kingdom
- Research Site
Sutton, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2014
- Primary completion
- 29 Nov 2016
- Completion
- 30 Mar 2017
- Last update posted
- 13 Sept 2019
- Registered enrollment
- 31
- Registry id
- NCT01894243
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.